Cite
Hoefnagel CA, Rutgers M, Buitenhuis CK, et al. A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur J Nucl Med. 2001;28(3):359-68doi: 10.1007/s002590000454.
Hoefnagel, C. A., Rutgers, M., Buitenhuis, C. K., Smets, L. A., Kraker, J. d., Meli, M., Carrel, F., Amstutz, H., Schubiger, P. A., & Novak-Hofer, I. (2001). A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. European journal of nuclear medicine, 28(3), 359-68. https://doi.org/10.1007/s002590000454
Hoefnagel, C A, et al. "A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients." European journal of nuclear medicine vol. 28,3 (2001): 359-68. doi: https://doi.org/10.1007/s002590000454
Hoefnagel CA, Rutgers M, Buitenhuis CK, Smets LA, Kraker Jd, Meli M, Carrel F, Amstutz H, Schubiger PA, Novak-Hofer I. A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur J Nucl Med. 2001 Mar;28(3):359-68. doi: 10.1007/s002590000454. PMID: 24623005.
Copy
Download .nbib